Adverse Events For Generic Of GSK's Advair Diskus On US FDA’s Radar

 
• By Derrick Gingery
Survelliance camera
The FDA Office of Generic Drugs does not want differences between complex generics and their reference products to hinder generic uptake. • Source: Shutterstock

More from Generics

More from Biosimilars & Generics